Skip to main content
Premium Trial:

Request an Annual Quote

Xanthon Cuts Staff In Half as Venture Capital Remains Elusive

NEW YORK, April 15 - Xanthon has laid off approximately half its existing staff as it struggles to find private-equity financing, the company's COO and interim CEO, Neil Moore, told GenomeWeb.

 

The job cuts, made on April 9, brought the company's head count to 17 full-time employees and comes after 10 staffers were laid off in the fall.

"We continue to talk to funds, we think we have a good story, and we had to make some decisions to conserve the cash we had," Moore said.

The company's latest financing, announced in January, was a Small Business Innovation Research grant from the United States Army worth roughly $70,000. Cash from that grant was to help Xanthon study the feasibility of developing a portable electrochemical DNA biosensor.

Technology being developed by Research Triangle Park, NC-based Xanthon is built on an electrochemical platform that helps detect nucleic acids without the need for sample preparation, amplification, of the use of fluorescent, chemiluminescent, or radioactive labels.

 

A shortage of cash delayed the product's launch, which was scheduled for earlier in the year. A new launch date has not yet been set.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.